Acer Therapeutics Inc. Quarterly Operating Lease, Payments in USD from Q1 2019 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Acer Therapeutics Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2019 to Q3 2023.
  • Acer Therapeutics Inc. Operating Lease, Payments for the quarter ending September 30, 2023 was $61K, a 126% increase year-over-year.
  • Acer Therapeutics Inc. Operating Lease, Payments for the twelve months ending September 30, 2023 was $112K, a 50.7% decline year-over-year.
  • Acer Therapeutics Inc. annual Operating Lease, Payments for 2022 was $200K, a 33.3% decline from 2021.
  • Acer Therapeutics Inc. annual Operating Lease, Payments for 2021 was $300K, unchanged from 2020.
  • Acer Therapeutics Inc. annual Operating Lease, Payments for 2020 was $300K, a 50% increase from 2019.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 $112K $61K +$34K +126% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-20
Q2 2023 $78K $47K -$53K -53% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $131K $31K -$69K -69% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $200K -$27K -$27K Oct 1, 2022 Dec 31, 2022 10-K 2023-03-27
Q3 2022 $227K $27K -$73K -73% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-20
Q2 2022 $300K $100K $0 0% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $300K $100K $0 0% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $300K $0 $0 Oct 1, 2021 Dec 31, 2021 10-K 2023-03-27
Q3 2021 $300K $100K $0 0% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $300K $100K $0 0% Apr 1, 2021 Jun 30, 2021 10-Q/A 2022-11-14
Q1 2021 $300K $100K $0 0% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $300K $0 +$28K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-02
Q3 2020 $272K $100K $0 0% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-19
Q2 2020 $272K $100K $0 0% Apr 1, 2020 Jun 30, 2020 10-Q/A 2021-11-19
Q1 2020 $272K $100K +$72K +257% Jan 1, 2020 Mar 31, 2020 10-Q/A 2021-11-19
Q4 2019 $200K -$28K Oct 1, 2019 Dec 31, 2019 10-K 2021-03-01
Q3 2019 $100K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 $100K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 $28K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.